Global Liquid-Filled Hard Capsules Market Outlook 2026-2031 - Growing Demand for Enhanced Drug Bioavailability Drives Growth
Dublin, Aug. 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Filled Hard Capsules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global liquid filled hard capsules market is projected to grow from USD 1.9 billion in 2025 and USD 1.99 billion in 2026 to USD 2.85 billion by 2031. The market is expected to register a compound annual growth rate of 7.45% from 2026 to 2031, supported by increasing demand for advanced drug delivery systems, plant-based capsule shells and stable oral dosage formats.
Bioavailability Requirements Accelerate Liquid-Fill Adoption
The growing number of small-molecule drug candidates with low aqueous solubility is encouraging pharmaceutical developers to adopt lipid-based liquid-fill strategies, including self-emulsifying drug delivery systems and self-microemulsifying drug delivery systems. These approaches can improve dissolution, absorption and consistency of drug exposure, making liquid filled hard capsules particularly valuable for BCS Class II and IV compounds.
Manufacturers are also selecting capsule shell materials that reduce the risk of cross-linking and moisture-related degradation. These formulation and material advances help maintain consistent dissolution performance throughout product shelf life. Regulatory expectations and quality-by-design practices are further supporting predictable development, validation and commercial scale-up for liquid oral dosage forms.
Nutraceutical Growth Supports Market Expansion
Rising consumer demand for convenient, single-dose health products is increasing the use of liquid filled hard capsules for vitamins, oils, enzymes, probiotics and botanical ingredients. Manufacturers are using advanced sealing technologies and enhanced oxygen barriers to protect oxidation-sensitive ingredients, including omega-3 oils and CoQ10, while improving tamper evidence and product stability.
Hydroxypropyl methylcellulose capsules are gaining traction in probiotic, enzyme and moisture-sensitive formulations. Their compatibility with delayed-release and modified-release applications supports product performance while meeting demand for vegan, non-GMO and halal-certified options. Taste masking, ease of swallowing and clean-label positioning are also strengthening the role of liquid filled hard capsules in consumer health portfolios.
Shell Material Trends Highlight Continued HPMC Growth
Gelatin capsules accounted for 73.24% of the liquid filled hard capsules market in 2025. Their leadership reflects established manufacturing infrastructure, mature supply networks and well-understood dissolution characteristics across oil-based liquids and suspension formulations. Gelatin remains well suited to high-volume programs involving stable oils and compatible excipients.
HPMC capsules are forecast to grow at a CAGR of 8.51% through 2031. Growth is being driven by lower shell moisture, resistance to aldehyde-related cross-linking and compatibility with moisture-sensitive active pharmaceutical ingredients, probiotics, enzymes and solvent-containing fills. Advances in polymer engineering and thermogelation are also improving pH-independent dissolution and supporting more sophisticated release profiles.
Oil-Based Fills Lead as Self-Emulsifying Systems Gain Momentum
Oil-based liquid fills represented 45.32% of the market in 2025, reflecting their broad use in vitamins, nutritional oils and hormone products. These formulations offer process simplicity, stable handling and compatibility with gelatin and HPMC shells. Equipment improvements in dosing accuracy, temperature control, in-line monitoring and high-speed filling are reinforcing their commercial appeal.
Self-emulsifying formulations are expected to record a CAGR of 9.85% through 2031 as pharmaceutical developers pursue improved solubilization and more consistent absorption for challenging active ingredients. Suspensions and semi-solid or hot-melt fills will continue to serve formulations involving low oil solubility or specialized release requirements, although these formats require robust controls for sedimentation, viscosity and thermal processing.
Sealing Complexity Remains a Market Restraint
Liquid filled hard capsules frequently require banding or fusion sealing to maintain container-closure integrity. Although these technologies improve leak prevention, oxidative protection and tamper evidence, they also require specialized equipment, process validation and skilled operators. Additional controls for fill weight, seal integrity and capsule appearance can increase manufacturing costs and complicate technology transfers, particularly for smaller batches and frequent product changeovers.
Excipient-shell interactions also require extensive compatibility testing and validation. These cost and operational considerations may limit adoption in highly price-sensitive programs, while encouraging pharmaceutical and nutraceutical companies to work with specialized contract development and manufacturing partners.
Regional Market Outlook
North America held 34.56% of the global liquid filled hard capsules market in 2025. The region benefits from an established pharmaceutical industry, mature regulatory systems and significant high-throughput manufacturing capacity. Demand for fusion-sealed and HPMC capsules is increasing in applications where oxidative stability, modified release and premium labeling claims are important.
Asia-Pacific is projected to be the fastest-growing regional market, with a CAGR of 9.32% through 2031. Expanding pharmaceutical and nutraceutical manufacturing, equipment modernization and rising adoption of vegetarian and halal-certified capsules are supporting growth. Europe is also expected to advance steadily, driven by rigorous quality standards, validated liquid-fill processes and strong demand for moisture management, advanced sealing and specialized release technologies.
Through 2031, the liquid filled hard capsules market is expected to benefit from continued innovation in shell materials, dosing systems, sealing accuracy and lipid-based formulations. Suppliers that integrate formulation development, capsule selection, filling and sealing capabilities will be well positioned to address evolving pharmaceutical and nutraceutical requirements.
Key Topics Covered:
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Bioavailability Push for Poorly Soluble APIs (Lipid-Based Fills, SEDDS/SMEDDS)
4.2.2 Nutraceutical Growth and Capsule Preference
4.2.3 Advances in Liquid Dosing and Sealing Accuracy
4.2.4 HPMC Adoption for Moisture-Sensitive and Vegetarian Formulations
4.2.5 High-Throughput Capsule Machinery Enabling LFHC Scale-Up
4.2.6 Banding/Fusion Sealing Enabling Tamper-Evidence and Premiumization
4.3 Market Restraints
4.3.1 Specialized Sealing Adds Cost and Process Complexity
4.3.2 Excipient-Shell Compatibility and Regulatory Validation Burdens
4.3.3 Gelatin Supply and Cultural Constraints Create Volatility
4.3.4 Oxygen/Moisture Ingress Risk Without Advanced Sealing/Packaging
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Shell Material
5.1.1 Gelatin
5.1.2 HPMC
5.1.3 Pullulan / Other Cellulose
5.2 By Filling State
5.2.1 Oil-based liquids
5.2.2 Suspensions
5.2.3 Semi-solid / Hot-melt fills
5.2.4 Self-emulsifying (SEDDS/SMEDDS)
5.3 By Sealing Method
5.3.1 Banding
5.3.2 Fusion sealing / LEMS microspray
5.3.3 Lock-only
5.4 By End Use
5.4.1 Rx Pharmaceuticals
5.4.2 OTC
5.4.3 Nutraceuticals / Dietary Supplements
5.5 By Release Profile
5.5.1 Immediate Release
5.5.2 Modified Release (Sustained / Enteric)
5.6 By Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 India
5.6.3.3 Japan
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East and Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East and Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 ACG
6.3.2 Aenova Group
6.3.3 Ascendia Pharmaceutical Solutions
6.3.4 Catalent, Inc
6.3.5 CapsCanada
6.3.6 Farmacapsulas
6.3.7 HealthCaps India Ltd
6.3.8 I.M.A. Industria Macchine Automatiche S.p.A.
6.3.9 Lonza
6.3.10 MG2 s.r.l.
6.3.11 Qualicaps
6.3.12 Roxlor LLC
6.3.13 SaintyCo
6.3.14 SEJONG PHARMATECH
6.3.15 Sirio Pharma
6.3.16 Suheung (EMBO CAPS)
6.3.17 Sunil HealthCare Limited
6.3.18 Syntegon Technology GmbH
6.3.19 Vantage Nutrition
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
For more information about this report visit https://www.researchandmarkets.com/r/5n2hd6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.